MeiraGTx Holdings PLC (MGTX) Reports Q1 Loss, Misses Revenue Estimates MeiraGTx (MGTX) delivered earnings and revenue surprises of -34.21% and 76.85%, respectively, for the quarter ended March 2025. Do the…
MeiraGTx Announces Third Quarter 2024 Financial and Operational Results and Recent Business Updates LONDON and NEW YORK, Nov. 13, 2024 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage genetic…
MeiraGTx Holdings PLC (MGTX) Reports Q2 Loss, Lags Revenue Estimates MeiraGTx (MGTX) delivered earnings and revenue surprises of -145.16% and 98.28%, respectively, for the quarter ended June 2024. Do the…